{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:06:14Z","timestamp":1767009974284,"version":"3.48.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["62993"],"award-info":[{"award-number":["62993"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["1338"],"award-info":[{"award-number":["1338"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00430-025-00866-8","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:26:33Z","timestamp":1767007593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel TamA\u2009+\u2009LtgC bivalent vaccine induces potent immunogenic and bactericidal antibodies against Neisseria gonorrhoeae"],"prefix":"10.1007","volume":"215","author":[{"given":"Narjes","family":"Noori Goodarzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheila","family":"Ajdary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Torkamaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Aminharati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Pourmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Badmasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"1","key":"866_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.ju.0000141496.59533.b2","volume":"173","author":"JC Nickel","year":"2005","unstructured":"Nickel JC (2005) Management of urinary tract infections: historical perspective and current strategies: part 1\u2013Before antibiotics. J Urol 173(1):21\u201326","journal-title":"J Urol"},{"issue":"5","key":"866_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/microorganisms12050884","volume":"12","author":"J Col\u00f3n P\u00e9rez","year":"2024","unstructured":"Col\u00f3n P\u00e9rez J, Villarino Fern\u00e1ndez R-A, Dom\u00ednguez Lago A, Trevi\u00f1o Castellano MM, P\u00e9rez del Molino Bernal ML, S\u00e1nchez Poza S et al (2024) Addressing sexually transmitted infections due to neisseria gonorrhoeae in the present and future. Microorganisms 12(5):884","journal-title":"Microorganisms"},{"issue":"8","key":"866_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/0956462420922462","volume":"31","author":"M Rajabpour","year":"2020","unstructured":"Rajabpour M, Emamie AD, Pourmand MR, Goodarzi NN, Asbagh FA, Whiley DM (2020) Chlamydia trachomatis, neisseria gonorrhoeae, and Trichomonas vaginalis among women with genitourinary infection and pregnancy-related complications in tehran: a cross-sectional study. Int J STD AIDS 31(8):773\u2013780","journal-title":"Int J STD AIDS"},{"key":"866_CR4","first-page":"17","volume":"9","author":"S Nekahiwot","year":"2024","unstructured":"Nekahiwot S, Debela N (2024) Multi-Drug resistant gonorrhea: an emerging global threat. Int J Infect Dis Therapy 9:17\u201325","journal-title":"Int J Infect Dis Therapy"},{"key":"866_CR5","first-page":"100364","volume":"16","author":"Y Li","year":"2022","unstructured":"Li Y, R\u00f6nn MM, Tuite AR, Chesson HW, Gift TL, Trikalinos TA et al (2022) Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the united states: a modelling study of overall burden and disparities by age, race\/ethnicity, and other factors. Lancet Reg Health Am 16:100364","journal-title":"Lancet Reg Health Am"},{"key":"866_CR6","first-page":"49","volume":"30","author":"A Hassain","year":"2023","unstructured":"Hassain A, Abdulrahman T, Salman J, Occurrence O (2023) CTX-M I gene in beta lactam resistance neisseria gonorrhoeae isolated form women with endocervical infection e50 occurrence of CTX-M I gene in beta lactam resistance neisseria gonorrhoeae isolated form women with endocervical infection. J Popl Ther Clin Pharmacol 30:49\u201353","journal-title":"J Popl Ther Clin Pharmacol"},{"issue":"11","key":"866_CR7","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","volume":"2","author":"M Unemo","year":"2021","unstructured":"Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P et al (2021) WHO global antimicrobial resistance surveillance for neisseria gonorrhoeae 2017\u201318: a retrospective observational study. Lancet Microbe 2(11):e627\u2013e36","journal-title":"Lancet Microbe"},{"key":"866_CR8","unstructured":"WHO Bacterial Priority Pathogens List (2024) Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO"},{"issue":"1","key":"866_CR9","first-page":"34","volume":"14","author":"L Greenberg","year":"1975","unstructured":"Greenberg L (1975) Field trials of a gonococcal vaccine. J Reprod Med 14(1):34\u201336","journal-title":"J Reprod Med"},{"issue":"3","key":"866_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","volume":"9","author":"JW Boslego","year":"1991","unstructured":"Boslego JW, Tramont EC, Chung RC, McChesney DG, Ciak J, Sadoff JC et al (1991) Efficacy trial of a parenteral gonococcal Pilus vaccine in men. Vaccine 9(3):154\u2013162","journal-title":"Vaccine"},{"issue":"5","key":"866_CR11","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1084\/jem.168.5.1883","volume":"168","author":"LM Wetzler","year":"1988","unstructured":"Wetzler LM, Blake MS, Gotschlich EC (1988) Characterization and specificity of antibodies to protein I of neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations. J Exp Med 168(5):1883\u20131897","journal-title":"J Exp Med"},{"key":"866_CR12","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3389\/fimmu.2019.02417","volume":"10","author":"MW Russell","year":"2019","unstructured":"Russell MW, Jerse AE, Gray-Owen SD (2019) Progress toward a gonococcal vaccine: the way forward. Front Immunol 10:2417","journal-title":"Front Immunol"},{"issue":"28","key":"866_CR13","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.vaccine.2020.02.073","volume":"38","author":"SL Gottlieb","year":"2020","unstructured":"Gottlieb SL, Ndowa F, Hook EW, Deal C, Bachmann L, Abu-Raddad L et al (2020) Gonococcal vaccines: public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine 38(28):4362\u20134373","journal-title":"Vaccine"},{"key":"866_CR14","doi-asserted-by":"publisher","first-page":"127188","DOI":"10.1016\/j.vaccine.2025.127188","volume":"56","author":"I Szondy","year":"2025","unstructured":"Szondy I, L\u0151rincz K, Walter A, Mohammed AA, Hegyi P, Kiss N et al (2025) Evaluating cross-protection: meningococcal vaccines show effectiveness in gonorrhoea prevention\u2014a systematic review and meta-analysis. Vaccine 56:127188","journal-title":"Vaccine"},{"issue":"1","key":"866_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41541-024-01018-4","volume":"9","author":"YL Tzeng","year":"2024","unstructured":"Tzeng YL, Sannigrahi S, Stephens DS (2024) NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against neisseria gonorrhoeae. NPJ Vaccines 9(1):223","journal-title":"NPJ Vaccines"},{"key":"866_CR16","doi-asserted-by":"publisher","first-page":"109265","DOI":"10.1016\/j.intimp.2022.109265","volume":"113","author":"M Negahdaripour","year":"2022","unstructured":"Negahdaripour M, Vakili B, Nezafat N (2022) Exosome-based vaccines and their position in next generation vaccines. Int Immunopharmacol 113:109265","journal-title":"Int Immunopharmacol"},{"key":"866_CR17","doi-asserted-by":"publisher","first-page":"1473193","DOI":"10.3389\/fimmu.2024.1473193","volume":"15","author":"Q Lu","year":"2024","unstructured":"Lu Q, Yang H, Peng Y, Dong Z, Nie P, Wang G et al (2024) Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against neisseria gonorrhoeae. Front Immunol 15:1473193","journal-title":"Front Immunol"},{"key":"866_CR18","doi-asserted-by":"publisher","first-page":"xtae031","DOI":"10.1093\/femsmc\/xtae031","volume":"5","author":"LN Lam","year":"2024","unstructured":"Lam LN, Sedra A, Kajfasz J, Berges A, Saengpet IS, Adams G et al (2024) Trivalent immunization with metal-binding proteins confers protection against enterococci in a mouse infection model. FEMS Microbes 5:xtae031","journal-title":"FEMS Microbes"},{"issue":"11","key":"866_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/14760584.2017.1379396","volume":"16","author":"SV Vemula","year":"2017","unstructured":"Vemula SV, Sayedahmed EE, Sambhara S, Mittal SK (2017) Vaccine approaches conferring cross-protection against influenza viruses. Expert Rev Vaccines 16(11):1141\u20131154","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"866_CR20","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s44319-024-00111-y","volume":"25","author":"KJ Goh","year":"2024","unstructured":"Goh KJ, Stubenrauch CJ, Lithgow T (2024) The TAM, a translocation and assembly module for protein assembly and potential conduit for phospholipid transfer. EMBO Rep 25(4):1711\u20131720","journal-title":"EMBO Rep"},{"issue":"7","key":"866_CR21","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","volume":"15","author":"RA Zielke","year":"2016","unstructured":"Zielke RA, Wierzbicki IH, Baarda BI, Gafken PR, Soge OO, Holmes KK et al (2016) Proteomics-driven antigen discovery for development of vaccines against gonorrhea. Mol Cell Proteom 15(7):2338\u20132355","journal-title":"Mol Cell Proteom"},{"issue":"22","key":"866_CR22","doi-asserted-by":"publisher","first-page":"7811","DOI":"10.1128\/JB.186.22.7811-7814.2004","volume":"186","author":"KA Cloud","year":"2004","unstructured":"Cloud KA, Dillard JP (2004) Mutation of a single lytic transglycosylase causes aberrant septation and inhibits cell separation of neisseria gonorrhoeae. J Bacteriol 186(22):7811\u20137814","journal-title":"J Bacteriol"},{"issue":"3","key":"866_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/mdr.2012.0001","volume":"18","author":"YA Chan","year":"2012","unstructured":"Chan YA, Hackett KT, Dillard JP (2012) The lytic transglycosylases of neisseria gonorrhoeae. Microb Drug Resist 18(3):271\u2013279","journal-title":"Microb Drug Resist"},{"issue":"11","key":"866_CR24","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.4049\/jimmunol.167.11.6487","volume":"167","author":"DM Granoff","year":"2001","unstructured":"Granoff DM, Moe GR, Giuliani MM, Adu-Bobie J, Santini L, Brunelli B et al (2001) A novel mimetic antigen eliciting protective antibody to neisseria meningitidis1. J Immunol 167(11):6487\u20136496","journal-title":"J Immunol"},{"key":"866_CR25","doi-asserted-by":"publisher","first-page":"105449","DOI":"10.1016\/j.meegid.2023.105449","volume":"112","author":"N Noori Goodarzi","year":"2023","unstructured":"Noori Goodarzi N, Ajdary S, Yekaninejad MS, Fereshteh S, Pourmand MR, Badmasti F (2023) Reverse vaccinology approaches to introduce promising immunogenic and drug targets against antibiotic-resistant neisseria gonorrhoeae: thinking outside the box in current prevention and treatment. Infect Genet Evol 112:105449","journal-title":"Infect Genet Evol"},{"issue":"1","key":"866_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12967-025-06256-1","volume":"23","author":"N Noori Goodarzi","year":"2025","unstructured":"Noori Goodarzi N, Barzi SM, Ajdary S, Chiani M, Yekaninejad MS, Badmasti F et al (2025) Immunogenic evaluation of LptD\u2009+\u2009LtgC as a bivalent vaccine candidate against neisseria gonorrhoeae. J Transl Med 23(1):261","journal-title":"J Transl Med"},{"issue":"6","key":"866_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1139\/cjm-2016-0528","volume":"63","author":"W He","year":"2017","unstructured":"He W, Shu J, Zhang J, Liu Z, Xu J, Jin X et al (2017) Expression, purification, and renaturation of a recombinant peptide-based HIV vaccine in Escherichia coli. Can J Microbiol 63(6):493\u2013501","journal-title":"Can J Microbiol"},{"issue":"4","key":"866_CR28","first-page":"850","volume":"54","author":"G Narjes Noori","year":"2025","unstructured":"Narjes Noori G, Shaghayegh Z, Naghmeh P, Soheila A, Mir Saeed Y, Mohammad P et al (2025) Exploring the prevalence of neisseria gonorrhoeae in women with genitourinary symptoms in Tehran, Iran. Iran J Public Health 54(4):850","journal-title":"Iran J Public Health"},{"key":"866_CR29","first-page":"338","volume":"58","author":"J Yano Jr.","year":"2011","unstructured":"Yano J, Fidel PL Jr. (2011) Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis. J Vis Exp 58:338","journal-title":"J Vis Exp"},{"issue":"4","key":"866_CR30","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s10989-020-10056-0","volume":"26","author":"I Rasooli","year":"2020","unstructured":"Rasooli I, Abdolhamidi R, Jahangiri A, Darvish Alipour Astaneh S (2020) Outer membrane protein, Oma87 prevents acinetobacter baumannii infection. Int J Pept Res Ther 26(4):2653\u20132660","journal-title":"Int J Pept Res Ther"},{"key":"866_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-1-0716-1900-1_19","volume":"2414","author":"EA Semchenko","year":"2022","unstructured":"Semchenko EA, Jen FE, Jennings MP, Seib KL (2022) Assessment of serum bactericidal and opsonophagocytic activity of antibodies to gonococcal vaccine targets. Methods Mol Biol 2414:363\u2013372","journal-title":"Methods Mol Biol"},{"issue":"9","key":"866_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/apm.12252","volume":"122","author":"A Keyhani","year":"2014","unstructured":"Keyhani A, Riazi-Rad F, Pakzad SR, Ajdary S (2014) Human polymorphonuclear leukocytes produce cytokines in response to leishmania major promastigotes. Apmis 122(9):891\u2013897","journal-title":"Apmis"},{"issue":"2","key":"866_CR33","doi-asserted-by":"publisher","first-page":"2249124","DOI":"10.1080\/22221751.2023.2249124","volume":"12","author":"S Song","year":"2023","unstructured":"Song S, Wang S, Jiang X, Yang F, Gao S, Lin X et al (2023) Th1-polarized MtrE-based gonococcal vaccines display prophylactic and therapeutic efficacy. Emerg Microbes Infect 12(2):2249124","journal-title":"Emerg Microbes Infect"},{"issue":"51","key":"866_CR34","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1016\/j.vaccine.2020.10.077","volume":"38","author":"AE Sikora","year":"2020","unstructured":"Sikora AE, Gomez C, Le Van A, Baarda BI, Darnell S, Martinez FG et al (2020) A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection. Vaccine 38(51):8175\u20138184","journal-title":"Vaccine"},{"key":"866_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fimmu.2013.00128","volume":"4","author":"F Fiorino","year":"2013","unstructured":"Fiorino F, Pettini E, Pozzi G, Medaglini D, Ciabattini A (2013) Prime-boost strategies in mucosal immunization affect local IgA production and the type of Th response. Front Immunol 4:128","journal-title":"Front Immunol"},{"issue":"1","key":"866_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/14760584.2024.2331065","volume":"23","author":"VM Vashishtha","year":"2024","unstructured":"Vashishtha VM, Kumar P (2024) The durability of vaccine-induced protection: an overview. Expert Rev Vaccines 23(1):389\u2013408","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"866_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/v12010074","volume":"12","author":"B Chackerian","year":"2020","unstructured":"Chackerian B, Peabody DS (2020) Factors that govern the induction of long-lived antibody responses. Viruses 12(1):74","journal-title":"Viruses"},{"issue":"4","key":"866_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya M, Kwak K, Pierce SK (2020) B cell memory: building two walls of protection against pathogens. Nat Rev Immunol 20(4):229\u2013238","journal-title":"Nat Rev Immunol"},{"key":"866_CR39","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3389\/fimmu.2018.01003","volume":"9","author":"P Xing","year":"2018","unstructured":"Xing P, Hong K, Niu X, Li S, Jun LV, Pan L (2018) Protection against helicobacter pylori infection in BALB\/c mouse model by oral administration of multivalent epitope-based vaccine of cholera toxin B Subunit-Huuc. Front Immunol 9:1003","journal-title":"Front Immunol"},{"issue":"6","key":"866_CR40","doi-asserted-by":"publisher","first-page":"e0250023","DOI":"10.1128\/mbio.02500-23","volume":"14","author":"S Gulati","year":"2023","unstructured":"Gulati S, Mattsson AH, Schussek S, Zheng B, DeOliveira RB, Shaughnessy J et al (2023) Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence. mBio 14(6):e0250023","journal-title":"mBio"},{"issue":"10","key":"866_CR41","doi-asserted-by":"publisher","first-page":"e0036422","DOI":"10.1128\/iai.00364-22","volume":"90","author":"AC Camire","year":"2022","unstructured":"Camire AC, O\u2019Bier NS, Patel DT, Cramer NA, Straubinger RK, Breitschwerdt EB et al (2022) FtlA and FtlB are candidates for inclusion in a next-generation multiantigen subunit vaccine for Lyme disease. Infect Immun 90(10):e0036422","journal-title":"Infect Immun"},{"issue":"4","key":"866_CR42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jinf.2016.02.002","volume":"72","author":"M Reglinski","year":"2016","unstructured":"Reglinski M, Lynskey NN, Choi YJ, Edwards RJ, Sriskandan S (2016) Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG. J Infect 72(4):450\u2013459","journal-title":"J Infect"},{"issue":"6","key":"866_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mbio.02600-19","volume":"10","author":"S Bi","year":"2019","unstructured":"Bi S, Xu M, Zhou Y, Xing X, Shen A, Wang B (2019) A multicomponent vaccine provides immunity against local and systemic infections by group a streptococcus across serotypes. mBio 10(6):10 https:\/\/doi.org\/10.1128\/mbio.02600-19","journal-title":"mBio"},{"issue":"8","key":"866_CR44","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/vaccines12080908","volume":"12","author":"M Naguib","year":"2024","unstructured":"Naguib M, Sharma S, Schneider A, Wehmueller S, Abdelaziz K (2024) Comparative effectiveness of various multi-antigen vaccines in controlling campylobacter jejuni in broiler chickens. Vaccines 12(8):908","journal-title":"Vaccines"},{"issue":"Suppl 2","key":"866_CR45","doi-asserted-by":"publisher","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","volume":"30","author":"D Serruto","year":"2012","unstructured":"Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R (2012) The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 30(Suppl 2):B87\u201397","journal-title":"Vaccine"},{"issue":"7","key":"866_CR46","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","volume":"73","author":"GA Price","year":"2005","unstructured":"Price GA, Russell MW, Cornelissen CN (2005) Intranasal administration of Recombinant neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect Immun 73(7):3945\u20133953","journal-title":"Infect Immun"},{"issue":"12","key":"866_CR47","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/vaccines11121846","volume":"11","author":"SK Roe","year":"2023","unstructured":"Roe SK, Felter B, Zheng B, Ram S, Wetzler LM, Garges E et al (2023) In vitro pre-clinical evaluation of a gonococcal trivalent candidate vaccine identified by transcriptomics. Vaccines (Basel) 11(12):1846","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"866_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.celrep.2018.09.029","volume":"25","author":"MC Woodruff","year":"2018","unstructured":"Woodruff MC, Kim EH, Luo W, Pulendran B (2018) B cell competition for restricted T cell help suppresses Rare-Epitope responses. Cell Rep 25(2):321\u20137e3","journal-title":"Cell Rep"},{"key":"866_CR49","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3389\/fimmu.2019.01256","volume":"10","author":"SK Singh","year":"2019","unstructured":"Singh SK, Thrane S, Chourasia BK, Teelen K, Graumans W, Stoter R et al (2019) Pfs230 and Pfs48\/45 fusion proteins elicit strong transmission-blocking antibody responses against plasmodium falciparum. Front Immunol 10:1256","journal-title":"Front Immunol"},{"issue":"12","key":"866_CR50","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/2211-5463.13498","volume":"12","author":"LV Michel","year":"2022","unstructured":"Michel LV, Kaur R, Gleghorn ML, Holmquist M, Pryharski K, Perdue J et al (2022) Haemophilus influenzae protein D antibody suppression in a multi-component vaccine formulation. FEBS Open Bio 12(12):2191\u20132202","journal-title":"FEBS Open Bio"},{"key":"866_CR51","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3389\/fimmu.2018.03187","volume":"9","author":"A Lovett","year":"2018","unstructured":"Lovett A, Duncan JA (2018) Human immune responses and the natural history of neisseria gonorrhoeae infection. Front Immunol 9:3187","journal-title":"Front Immunol"},{"issue":"12 Suppl 2","key":"866_CR52","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/infdis\/jiaa766","volume":"224","author":"MW Russell","year":"2021","unstructured":"Russell MW (2021) Immune responses to neisseria gonorrhoeae: challenges and opportunities with respect to pelvic inflammatory disease. J Infect Dis 224(12 Suppl 2):S96\u2013s102","journal-title":"J Infect Dis"},{"issue":"3","key":"866_CR53","doi-asserted-by":"publisher","first-page":"e00095","DOI":"10.1128\/mBio.00095-11","volume":"2","author":"Y Liu","year":"2011","unstructured":"Liu Y, Russell MW (2011) Diversion of the immune response to neisseria gonorrhoeae from Th17 to Th1\/Th2 by treatment with anti-transforming growth factor \u03b2 antibody generates immunological memory and protective immunity. mBio 2(3):e00095\u2013e00011","journal-title":"mBio"},{"issue":"1","key":"866_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/mi.2013.36","volume":"7","author":"Y Liu","year":"2014","unstructured":"Liu Y, Liu W, Russell MW (2014) Suppression of host adaptive immune responses by neisseria gonorrhoeae: role of Interleukin 10 and type 1 regulatory T cells. Mucosal Immunol 7(1):165\u2013176","journal-title":"Mucosal Immunol"},{"issue":"6","key":"866_CR55","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/mi.2017.11","volume":"10","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hammer LA, Liu W, Hobbs MM, Zielke RA, Sikora AE et al (2017) Experimental vaccine induces Th1-driven immune responses and resistance to neisseria gonorrhoeae infection in a murine model. Mucosal Immunol 10(6):1594\u20131608","journal-title":"Mucosal Immunol"},{"issue":"1","key":"866_CR56","doi-asserted-by":"publisher","first-page":"e0038822","DOI":"10.1128\/msphere.00388-22","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Hammer LA, Daamen J, Stork M, Egilmez NK, Russell MW, Microencapsulated (2023) IL-12 drives genital tract immune responses to intranasal gonococcal outer membrane vesicle vaccine and induces resistance to vaginal infection with diverse strains of neisseria gonorrhoeae. mSphere 8(1):e0038822","journal-title":"mSphere"},{"key":"866_CR57","doi-asserted-by":"publisher","first-page":"12486132023","DOI":"10.3389\/fimmu.2023.1248613","volume":"14","author":"T Belcher","year":"2023","unstructured":"Belcher T, Rollier CS, Dold C, Ross JDC, MacLennan CA (2023) Immune responses to neisseria gonorrhoeae and implications for vaccine development. Front Immunol 14:12486132023","journal-title":"Front Immunol"},{"key":"866_CR58","doi-asserted-by":"publisher","first-page":"1688536","DOI":"10.3389\/fimmu.2025.1688536","volume":"16","author":"SK Roe","year":"2025","unstructured":"Roe SK, Zheng B, Gulati S, Genco C, Ram S, Massari P (2025) Preclinical in vivo evaluation of a gonococcal multivalent vaccine containing antigens identified by CASS. Front Immunol 16:1688536","journal-title":"Front Immunol"},{"issue":"2","key":"866_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000049504","volume":"126","author":"AW Wheeler","year":"2001","unstructured":"Wheeler AW, Marshall JS, Ulrich JT (2001) A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. Int Arch Allergy Immunol 126(2):135\u2013139","journal-title":"Int Arch Allergy Immunol"},{"key":"866_CR60","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/infdis\/jiaf445","volume":"232","author":"KA Matthias","year":"2025","unstructured":"Matthias KA, Connolly KL, Jerse AE, Kumova OK, Macintyre AN, Gray MC et al (2025) Evaluation of immunization route in induction of vaccine-mediated anti-gonococcal immune responses in a murine model of ascending infection. J Infect Dis 232:765","journal-title":"J Infect Dis"},{"issue":"1","key":"866_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41541-025-01190-1","volume":"10","author":"M Spinsanti","year":"2025","unstructured":"Spinsanti M, Monaci E, Romagnoli G, Buffi G, Manetti AGO, Carboni F et al (2025) A novel GMMA-based gonococcal vaccine demonstrates functional immune responses in mice. Npj Vaccines 10(1):146","journal-title":"Npj Vaccines"},{"issue":"12","key":"866_CR62","doi-asserted-by":"publisher","first-page":"e1008602","DOI":"10.1371\/journal.ppat.1008602","volume":"16","author":"I Leduc","year":"2020","unstructured":"Leduc I, Connolly KL, Begum A, Underwood K, Darnell S, Shafer WM et al (2020) The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against neisseria gonorrhoeae. PLoS Pathog 16(12):e1008602","journal-title":"PLoS Pathog"},{"issue":"15","key":"866_CR63","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","volume":"23","author":"LC Freytag","year":"2005","unstructured":"Freytag LC, Clements JD (2005) Mucosal adjuvants. Vaccine 23(15):1804\u20131813","journal-title":"Vaccine"},{"issue":"2","key":"866_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/vaccines12020191","volume":"12","author":"Y Song","year":"2024","unstructured":"Song Y, Mehl F, Zeichner SL (2024) Vaccine strategies to elicit mucosal immunity. Vaccines 12(2):191","journal-title":"Vaccines"},{"issue":"3","key":"866_CR65","doi-asserted-by":"publisher","first-page":"e25733","DOI":"10.1016\/j.heliyon.2024.e25733","volume":"10","author":"L Xia","year":"2024","unstructured":"Xia L, Lu Q, Wang X, Jia C, Zhao Y, Wang G et al (2024) Characterization of protective immune responses against neisseria gonorrhoeae induced by intranasal immunization with adhesion and penetration protein. Heliyon 10(3):e25733","journal-title":"Heliyon"},{"issue":"45","key":"866_CR66","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1016\/j.vaccine.2008.08.020","volume":"26","author":"W Song","year":"2008","unstructured":"Song W, Condron S, Mocca BT, Veit SJ, Hill D, Abbas A et al (2008) Local and humoral immune responses against primary and repeat neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice. Vaccine 26(45):5741\u20135751","journal-title":"Vaccine"},{"issue":"9","key":"866_CR67","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1086\/513279","volume":"195","author":"BT Galen","year":"2007","unstructured":"Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS et al (2007) A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. J Infect Dis 195(9):1332\u20131339","journal-title":"J Infect Dis"},{"issue":"71, 2017","key":"866_CR68","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","volume":"71","author":"PA Rice","year":"2017","unstructured":"Rice PA, Shafer WM, Ram S, Jerse AE (2017) Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development. Annu Rev Microbiol 71(71, 2017):665\u2013686","journal-title":"Annu Rev Microbiol"},{"key":"866_CR69","doi-asserted-by":"publisher","first-page":"840122","DOI":"10.3389\/fcimb.2022.840122","volume":"12","author":"M Heydarian","year":"2022","unstructured":"Heydarian M, R\u00fchl E, Rawal R, Kozjak-Pavlovic V (2022) Tissue models for neisseria gonorrhoeae research-from 2D to 3D. Front Cell Infect Microbiol 12:840122","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"866_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/vaccines8020219","volume":"8","author":"EA Semchenko","year":"2020","unstructured":"Semchenko EA, Day CJ, Seib KL (2020) The neisseria gonorrhoeae vaccine candidate NHBA elicits antibodies that are bactericidal, opsonophagocytic and that reduce gonococcal adherence to epithelial cells. Vaccines (Basel) 8(2):219","journal-title":"Vaccines (Basel)"},{"issue":"26","key":"866_CR71","doi-asserted-by":"publisher","first-page":"126416","DOI":"10.1016\/j.vaccine.2024.126416","volume":"42","author":"S Taha, Eskandari","year":"2024","unstructured":"Taha, Eskandari S, Slesarenko VA, Haselhorst T, Semchenko EA, Seib KL (2024) Refinement and optimisation of neisseria gonorrhoeae NHBA and MetQ vaccine candidates. Vaccine 42(26):126416","journal-title":"Vaccine"},{"issue":"2","key":"866_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/ecosalplus.esp-0036-2018","volume":"8","author":"CJ Stubenrauch","year":"2019","unstructured":"Stubenrauch CJ, Lithgow T (2019) The TAM: a translocation and assembly module of the \u03b2-Barrel assembly machinery in bacterial outer membranes. EcoSal Plus 8(2):10","journal-title":"EcoSal Plus"},{"issue":"7","key":"866_CR73","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","volume":"15","author":"RA Zielke","year":"2016","unstructured":"Zielke RA, Wierzbicki IH, Baarda BI, Gafken PR, Soge OO, Holmes KK et al (2016) Proteomics-driven antigen discovery for development of vaccines against Gonorrhea*. Mol Cell Proteom 15(7):2338\u20132355","journal-title":"Mol Cell Proteom"},{"issue":"4","key":"866_CR74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/vaccines7040153","volume":"7","author":"T Zhu","year":"2019","unstructured":"Zhu T, McClure R, Harrison OB, Genco C, Massari P (2019) Integrated bioinformatic analyses and immune characterization of new neisseria gonorrhoeae vaccine antigens expressed during natural mucosal infection. Vaccines (Basel) 7(4):153","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"866_CR75","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1086\/528994","volume":"197","author":"JA Welsch","year":"2008","unstructured":"Welsch JA, Ram S, Koeberling O, Granoff DM (2008) Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. J Infect Dis 197(7):1053\u20131061","journal-title":"J Infect Dis"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00866-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-025-00866-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00866-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:01:57Z","timestamp":1767009717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-025-00866-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s00430-025-00866-8","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"type":"print","value":"0300-8584"},{"type":"electronic","value":"1432-1831"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received ethical approval from the Research Ethics Committee of the Tehran University of Medical Sciences (approval ID: IR.TUMS.SPH.REC.1403.073).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"4"}}